KPRX

Kiora Pharmaceuticals, Inc. Common Stock

2.16

USD

KPRX Earnings Reports

Positive Surprise Ratio

KPRX beat 24 of 38 last estimates.

63%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$1.53M

-$0.68

Implied change from Q3 25 (Revenue/ EPS)

-6900.00%

Implied change from Q4 24 (Revenue/ EPS)

-34.62%

Kiora Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Nov 07, 2025, KPRX reported earnings of 0.01 USD per share (EPS) for Q3 25, beating the estimate of -0.74 USD, resulting in a 101.33% surprise. Revenue reached --, compared to an expected 765.00 thousand, with a -100.00% difference. The market reacted with a +0.43% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.68 USD, with revenue projected to reach 1.53 million USD, implying an decrease of -6900.00% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Kiora Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Kiora Pharmaceuticals, Inc. Common Stock reported EPS of $0.01, beating estimates by 101.33%, and revenue of $0.00, -100% below expectations.

How did the market react to Kiora Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 0.43%, changed from $2.32 before the earnings release to $2.33 the day after.

When is Kiora Pharmaceuticals, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Kiora Pharmaceuticals, Inc. Common Stock's next earnings report?

Based on 3 analysts, Kiora Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.68 and revenue of $1.53M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.